SPC394
Voxelotor eða ráphverfa eða lyfjafræðilega viðeigandi salt þess
:
Veitt:
29.7.2022:
15.8.2022:
15.2.2025
:
14.2.2037:
Oxbryta
29.7.2022
15.8.2022
15.2.2025
14.2.2037
:
EU/1/21/1622/001:
22.2.2022
:
EU/1/21/1622:
14.2.2022
:
Global Blood Therapeutics, Inc.:
181 Oyster Point Blvd., South San Francisco, CA 94080 US
:
Patice ehf.:
Pósthólf 8236, 128 Reykjavík